NUORA updates

Oral GLP-1 launch notes, without the noise.

Get concise NUORA updates on the UK weight-loss programme, safety content, eligibility guidance, and patient access milestones.

What we send

  • Oral GLP-1 launch notes and product availability
  • Pharmacist-reviewed safety and eligibility guidance
  • Patient journey improvements before the commercial launch

Reviewed content

Updates are written for patient acquisition and reviewed against the current NUORA launch scope.

Consent-first

You can unsubscribe from email links, and preference links remain separate from account and clinical messages.

Need legal details?

Read the Privacy Policy and Cookie Policy.

Was this page useful?

Your answer helps us improve the service journey.